Houston Methodist. Leading Medicine.
Houston Methodist. Leading Medicine

Oncology

Faculty - Oncology

Daniel E. Lehane, MD (Subspecialty Education Coordinator) is The Distinguished Chair of Medical Oncology. He received his medical degree from State University of New York at Buffalo School of Medicine, Buffalo, New York. He went on to his internship at Buffalo General Hospital in Buffalo and his residency and fellowship in Clinical Oncology at Baylor College of Medicine, Houston, TX. He is currently the Subspecialty Education Coordinator for Oncology at HMH. Dr. Lehane's research interests include brain tumors, breast cancer, chemotherapy, colon cancer, head and neck cancer, Hodgkins disease, lung cancer, lymphoma, oral cancer, prostate cancer and skin tumors.

Jenny C. Chang, MD is Director of the Cancer Center at Houston Methodist Hospital. She obtained her medical degree at Cambridge University in England, and completed fellowship training in medical oncology at the Royal Marsden Hospital/ Institute for Cancer Research in the United Kingdom. She was also awarded a research doctorate from the University of London. There, she developed an interest in breast cancer, particularly in the area of prognostic and predictive markers. Her recent work has focused on the intrinsic therapy resistance of cancer stem cells, resulting in several publications in high impact journals and international presentations. She is a world-renown clinical investigator, credited as one of the first to describe intrinsic chemoresistance of tumor-initiating cells.

Angel Augusto Rodriguez, MD is currently a member of Houston Methodist Cancer Center's Breast Oncology department. He completed internal medicine residency and fellowship in Medical Oncology and Hematology at Baylor College of Medicine and specialized in breast cancer as part of the Susan G. Komen for the Cure Breast Cancer Fellowship Program. Dr. Rodriguez has also served as a Baylor College of Medicine Clinical Instructor at Ben Taub General Hospital in Houston, TX. He joined Houston Methodist Cancer Center in March 2011 and is now Director of Houston Methodist Triple Negative Breast Cancer Clinic.

Monisha Singh, MD is a medical oncologist with interests in medical education, clinical practice and clinical research. She graduated from UCLA School of Medicine and went on to complete her residency in Internal Medicine at Harbor-UCLA Medical Center and her Hematology/Oncology Fellowship at Olive-View UCLA Medical Center/Cedars-Sinai Medical Center. She is a member of Alpha Omega Alpha. Dr. Singh is board-certified in internal medicine, hematology and medical oncology. Her interests include GI oncology, thoracic tumors, breast cancer, gynecologic cancers and lymphoma.